Best U.S. Cannabis Penny Stocks to Trade Now – July 2025 Watchlist

High-Volatility Cannabis Penny Stocks to Watch This Week

The U.S. cannabis industry continues to grow despite ongoing regulatory uncertainty. In 2024, sales approached $39 billion across medical and recreational markets. Looking ahead, analysts project consistent double-digit growth through the end of the decade. This week, investors are focusing on marijuana penny stocks due to their explosive potential. These low-priced equities often react strongly to news, earnings, and market momentum. Additionally, cannabis reform headlines and upcoming ballot initiatives have triggered renewed interest.

Because penny stocks can move quickly, technical analysis plays a key role. Traders are watching volume surges, trendline breaks, and key support levels. Likewise, breakout patterns and moving averages offer insight into possible upside. Even so, risks remain high. Therefore, disciplined risk management is essential. Proper stop losses, position sizing, and exit plans help limit downside. As volatility increases, smart preparation becomes a competitive edge. This week, several marijuana penny stocks are flashing strong technical signals for short-term setups.

Marijuana Penny Stocks Showing Bullish Setups

Momentum in marijuana reform remains a major driver for this sector. Although federal legalization has not yet passed, many states continue expanding access. New recreational markets and licensing approvals have lifted expectations heading into the second half of 2025. In response, marijuana penny stocks are experiencing sharp moves on even minor news. This makes timing and strategy more important than ever.

Traders are carefully analyzing price consolidation, resistance levels, and volume spikes to find potential entries. Additionally, some names are showing increased institutional interest. While that does not guarantee upside, it may confirm breakout potential. Still, it is critical to manage every trade with a plan. Setting realistic profit targets, honoring stops, and avoiding emotional entries helps preserve capital. Penny stocks remain unpredictable. However, with the right combination of technical analysis and risk control, they offer traders a chance to capture outsized gains. This week presents a strong setup for active cannabis investors.

The U.S. cannabis sector continues to evolve as legalization gains ground and consumer demand grows. Investors are watching key players that show strong fundamentals, state-level dominance, and strategic expansion. In July 2025, three U.S.-focused marijuana stocks stand out for their footprint, innovation, and growth. These include Planet 13 Holdings Inc. (PLNH), Cansortium Inc. (CNTMF), and Green Thumb Industries Inc. (GTBIF). Each company operates across high-demand markets and continues to adapt amid regulatory shifts. Additionally, technical traders are monitoring support and resistance levels for potential breakout setups. With careful risk management and ongoing analysis, these stocks could offer opportunity during the second half of 2025.

As always, traders should use proper entry and exit strategies. Cannabis stocks can remain volatile even in bullish conditions. Moreover, tracking earnings, volume patterns, and legislative news will be crucial. Let’s explore three companies leading the space this month.

[Read More] 3 Top Canadian Marijuana Stocks To Watch As The Sector Looks To Bounce

Top U.S. Marijuana Stocks to Watch in July 2025

  1. Planet 13 Holdings Inc. (OTC: PLNH)
  2. Cansortium Inc. (OTC: CNTMF)
  3. Green Thumb Industries Inc. (OTC: GTBIF)

Planet 13 Holdings Inc. (PLNH)

Planet 13 is one of the most recognized cannabis retail brands in the U.S. The company is best known for its Las Vegas SuperStore, which combines entertainment and retail. This flagship location attracts both tourists and local customers, setting it apart from competitors. Beyond Las Vegas, Planet 13 expanded into California and Florida through strategic acquisitions and licensing. Its California location, the Orange County SuperStore, is the second-largest in its portfolio. In Florida, the company holds multiple retail licenses and is growing its dispensary count steadily. As of July 2025, Planet 13 operates nine dispensaries and is actively pursuing new locations in both recreational and medical markets.

Furthermore, the company continues to focus on high-traffic areas to build brand visibility. Its retail-first strategy is designed to appeal to consumers seeking experience-driven cannabis shopping. With strong branding and premium store environments, Planet 13 is positioning itself for long-term dominance in destination markets.

Planet 13 recently reported financial results for the first quarter of 2025. The company recorded revenue of approximately $25.7 million. This figure represents a modest decline compared to the same quarter last year. However, management emphasized cost controls and margin protection as key areas of focus. Gross profit came in at $11.6 million, resulting in a 45.1% gross margin. Additionally, Planet 13 reduced general and administrative expenses by 7% year-over-year. Despite macroeconomic pressures, the company maintained a strong balance sheet, ending the quarter with $37 million in cash. Operating expenses were trimmed, and inventory turnover improved. The company also reaffirmed its guidance for 2025. Leadership expects a return to revenue growth in the second half of the year. Finally, the Florida expansion is expected to contribute positively to revenue starting in Q3 2025.

[Read More] Here’s How To Invest In Marijuana Stocks While The Sector Recovers

Cansortium Inc. (CNTMF)

Cansortium Inc., headquartered in Florida, operates under the Fluent Cannabis Care brand. The company has carved out a niche in Florida’s growing medical cannabis market. Fluent dispensaries focus on high-quality medical cannabis products and patient education. As of July 2025, Cansortium operates 35 dispensaries across Florida. It is also licensed to operate in Texas, Pennsylvania, and Michigan. However, the majority of its retail activity and brand presence is centered in Florida. The company has steadily grown its market share through new product releases and improved service. Fluent is known for its clean dispensary layouts, knowledgeable staff, and consistent branding.

CNTMF

Moreover, Cansortium has emphasized operational efficiency and loyalty marketing. Its rewards program continues to attract repeat customers. The Florida market, although medical-only, has proven resilient and profitable. Cansortium is leveraging this stability while eyeing future recreational legalization. Expansion in Texas and Pennsylvania is expected once favorable regulations are introduced.

In Q1 2025, Cansortium reported revenue of $24.2 million. This marked a slight decline from the previous quarter, due to seasonality and competitive pressure. Nevertheless, the company improved its gross margin to 57%, up from 52% a year ago. The improved margin was due to cost optimization in cultivation and processing. Adjusted EBITDA for the quarter came in at $6.1 million, reflecting disciplined expense management. Net loss was $1.5 million, which narrowed year-over-year from a $3.2 million loss. Additionally, the company ended the quarter with $7.8 million in cash. Cansortium reduced long-term debt by $1.4 million during the period. Capital expenditures remained low, helping preserve liquidity. Management reiterated its commitment to profitability and patient care. The company expects sequential revenue growth to return in Q3, especially with Florida patient counts rising steadily in 2025.

[Read More] Here’s How To Invest In Marijuana Stocks While The Sector Recovers

Green Thumb Industries Inc. (GTBIF)

Green Thumb Industries is one of the largest multi-state cannabis operators in the U.S. The company owns and operates retail stores under the “RISE” brand. GTI currently has more than 100 dispensaries across 14 states, including Illinois, Pennsylvania, and Ohio. Its biggest retail and cultivation footprints are in Illinois and Pennsylvania. GTI also owns several well-known product brands, such as Dogwalkers, Beboe, and Incredibles. This multi-brand portfolio allows GTI to serve various customer segments across medical and adult-use markets. As of July 2025, the company remains focused on improving operations and growing its wholesale partnerships.

Moreover, GTI continues to invest in high-return states and streamline supply chains. Its mix of retail and wholesale operations provides strategic flexibility. The company’s consistent brand strategy and national presence give it an edge. Additionally, it has a reputation for stable leadership and financial transparency, which investors find reassuring.

In its most recent earnings report, Green Thumb posted Q1 2025 revenue of $280 million. This reflected a year-over-year increase of 1.5%, despite overall industry headwinds. Gross profit totaled $143.3 million, yielding a 51.3% margin. Net income was $8.3 million, or $0.04 per share, slightly below analyst expectations. Adjusted EBITDA came in at $85.2 million, representing a 30.5% margin. Green Thumb ended the quarter with $210 million in cash and $252 million in debt. Management emphasized cash preservation and long-term sustainability. The company also reduced overhead and improved labor productivity. Capital expenditures were focused mainly on cultivation upgrades. Green Thumb maintained its forecast for moderate growth in 2025. Its leadership remains confident in long-term prospects as more states advance recreational reform.

Marijuana Penny Stocks Gaining Volume—Technical Setups for Traders

In July 2025, Planet 13, Cansortium, and Green Thumb Industries each offer unique exposure to the U.S. cannabis market. Planet 13 dominates in destination retail and brand appeal. Cansortium remains strong in Florida’s medical segment with improving margins. Green Thumb offers scale and consistency across multiple recreational states. With federal reform still evolving, investors should monitor legislation closely. Technical setups combined with fundamental research can offer strong risk-reward scenarios in these names.

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$HEMP Update and 25 Facts You May Not Know About the Marijuana Revolution

Hemp, Inc. (OTC PINK: HEMP) executives are pleased to report on the progress of…